Expression of multidrug resistance-associated markers, their relation to quantitative pathologic tumour characteristics and prognosis in advanced ovarian cancer

被引:26
作者
Brinkhuis, M
Izquierdo, MA
Baak, JPA
van Diest, PJ
Kenemans, P
Scheffer, GL
Scheper, RJ
机构
[1] Free Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
[2] Free Univ Amsterdam, Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands
来源
ANALYTICAL CELLULAR PATHOLOGY | 2002年 / 24卷 / 01期
关键词
ovary; carcinoma; multi drug resistance; prognosis; morphometry;
D O I
10.1155/2002/958436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mean nuclear area has been consistently shown by different researchers to be a strong and independent prognostic factor in advanced ovarian carcinoma. However, the biological background of the prognostic value of nuclear area remains unclear. Others have found that the multidrug-resistance (MDR) related protein LRP has strong prognostic value. In the present study we have analysed whether the mean nuclear area and LRP are related in tumour tissue of the ovary obtained at the debulking operation before the administration of chemotherapy in 40 patients. The mitotic activity index, volume percentage epithelium, standard deviation of nuclear area and the other MDR-related proteins P-glycoprotein (JSB-1, MRK-16) and MRP have been investigated additionally for correlations and prognostic value. No correlations were found between the morphometrical features and MDR-related proteins. Mean nuclear area tended to be larger in LRP positive tumours, but the correlation was not significant. In multivariate analysis LRP-protein expression and mean nuclear area had independent prognostic value. Further studies are required to elucidate the biological background of the strong prognostic value of mean nuclear area in advanced ovarian cancer.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 36 条
[1]  
ARAO S, 1994, CANCER RES, V54, P1355
[2]   THE PROGNOSTIC VALUE OF MORPHOMETRICAL FEATURES AND CELLULAR DNA CONTENT IN CISPLATIN TREATED LATE OVARIAN-CANCER PATIENTS [J].
BAAK, JPA ;
SCHIPPER, NW ;
WISSEBREKELMANS, ECM ;
CEELEN, T ;
BOSMAN, FT ;
VANGEUNS, H ;
WILS, J .
BRITISH JOURNAL OF CANCER, 1988, 57 (05) :503-508
[3]   POSSIBILITIES AND PROGRESS OF QUANTITATIVE PATHOLOGICAL EXAMINATION OF OVARIAN-TUMORS [J].
BAAK, JPA .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1988, 29 (03) :183-189
[4]   MORPHOMETRIC DATA TO FIGO STAGE AND HISTOLOGICAL TYPE AND GRADE FOR PROGNOSIS OF OVARIAN-TUMORS [J].
BAAK, JPA ;
WISSEBREKELMANS, ECM ;
LANGLEY, FA ;
TALERMAN, A ;
DELEMARRE, JFM .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (12) :1340-1346
[5]   PROGNOSTIC FACTORS IN BORDERLINE AND INVASIVE OVARIAN-TUMORS OF THE COMMON EPITHELIAL TYPE [J].
BAAK, JPA ;
CHAN, KK ;
STOLK, JG ;
KENEMANS, P .
PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (06) :755-774
[6]  
Beck W T, 1991, Semin Cancer Biol, V2, P235
[7]   CISPLATIN-DNA DAMAGE RECOGNITION PROTEINS IN HUMAN TUMOR EXTRACTS [J].
BISSETT, D ;
MCLAUGHLIN, K ;
KELLAND, LR ;
BROWN, R .
BRITISH JOURNAL OF CANCER, 1993, 67 (04) :742-748
[8]  
FLENS MJ, 1994, CANCER RES, V54, P4557
[9]  
FRIEDLANDER ML, 1991, SEMIN ONCOL, V18, P205
[10]   MULTIDRUG RESISTANCE IN HUMAN CANCER [J].
GOLDSTEIN, LJ ;
PASTAN, I ;
GOTTESMAN, MM .
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1992, 12 (03) :243-253